Submissions from 2019
Community paramedics treat high acuity conditions in the home: A prospective observational study, K. A. Abrashkin, A. Poku, A. Ramjit, J. Washko, J. Zhang, M. Guttenberg, and K. L. Smith
Electroconvulsive Therapy and Schizophrenia: A Systematic Review., S. A. Ali, N. Mathur, A. K. Malhotra, and R. J. Braga
Development of bipolar disorder and other comorbidity among youth with attention-deficit/hyperactivity disorder, L. E. Arnold, A. R. Van Meter, M. A. Fristad, E. A. Youngstrom, B. B. Birmaher, R. L. Findling, S. Horwitz, and S. R. Black
Age-Normative Pathways of Striatal Connectivity Related to Clinical Symptoms in the General Population, A. D. Barber, D. K. Sarpal, M. John, C. L. Fales, S. H. Mostofsky, A. K. Malhotra, K. H. Karlsgodt, T. Lencz, T. L. Jernigan, J. Gruen, and +27 additional authors
Objective User Engagement With Mental Health Apps: Systematic Search and Panel-Based Usage Analysis., A. Baumel, F. Muench, S. Edan, and J. Kane
Recruitment via social media: advantages and potential biases, C. Benedict, A. L. Hahn, M. A. Diefenbach, and J. S. Ford
Continuation Electroconvulsive Therapy for Patients With Clozapine-Resistant Schizophrenia A Pilot Study, R. J. Braga, M. John, N. R. Schooler, S. H. Bailine, C. Malur, A. Mendelowitz, and G. Petrides
The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning, B. B. Brodey, R. R. Girgis, O. V. Favorov, C. E. Bearden, S. W. Woods, J. Addington, D. O. Perkins, E. F. Walker, B. A. Cornblatt, K. S. Cadenhead, and +3 additional authors
Dysfunctional attitudes or extreme response style as predictors of depressive relapse and recurrence after mobile cognitive therapy for recurrent depression, M. E. Brouwer, A. D. Williams, N. R. Forand, R. J. DeRubeis, and C. L. Bockting
Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial, H. E. Brown, O. Freudenreich, X. Fan, S. O. Heard, D. Goff, G. Petrides, A. L. Harrington, J. M. Kane, H. Judge, R. H. Perlis, and +2 additional authors
Capturing behavioral indicators of persecutory ideation using mobile technology, B. Buck, K. A. Hallgren, E. Scherer, R. Brian, R. Wang, W. Wang, A. Campbell, M. Hauser, J. M. Kane, D. Ben-Zeev, and +1 additional author
Relationships between smartphone social behavior and relapse in schizophrenia: A preliminary report, B. Buck, E. Scherer, R. Brian, R. Wang, W. Wang, A. Campbell, T. Choudhury, M. Hauser, J. M. Kane, and D. Ben-Zeev
Progressive reconfiguration of resting-state brain networks as psychosis develops: Preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium, H. Cao, Y. Chung, S. C. McEwen, C. E. Bearden, J. Addington, B. Goodyear, K. S. Cadenhead, H. Mirzakhanian, B. A. Cornblatt, T. D. Cannon, and +13 additional authors
Altered brain activation during memory retrieval precedes and predicts conversion to psychosis in individuals at clinical high risk, H. Cao, S. C. McEwen, Y. Chung, O. Y. Chén, C. E. Bearden, J. Addington, B. Goodyear, K. S. Cadenhead, B. A. Cornblatt, T. D. Cannon, and +14 additional authors
Toward Leveraging Human Connectomic Data in Large Consortia: Generalizability of fMRI-Based Brain Graphs Across Sites, Sessions, and Paradigms, H. Cao, S. C. McEwen, J. K. Forsyth, D. G. Gee, C. E. Bearden, J. Addington, B. Goodyear, B. A. Cornblatt, R. E. Carrion, T. D. Cannon, and +14 additional authors
White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study., S. Cetin-Karayumak, M. A. Di Biase, N. Chunga, B. Reid, N. Somes, A. E. Lyall, S. Kelly, B. Solgun, A. K. Malhotra, M. Kubicki, and +21 additional authors
Cholinergic Control of Inflammation, Metabolic Dysfunction, and Cognitive Impairment in Obesity-Associated Disorders: Mechanisms and Novel Therapeutic Opportunities, E. H. Chang, S. S. Chavan, and V. A. Pavlovh
Cognitive function in aging cocaine smokers, T. Chao, M. Haney, Z. D. Cooper, N. P. Vadhan, N. T. Van Dam, J. Van Snellenberg, and G. Bedi
An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes, Z. Cheng, Y. Yuan, X. Han, L. Yang, S. Cai, F. Yang, Z. Lu, C. Wang, C. U. Correll, X. Yu, and +3 additional authors
Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study, Y. Chung, J. Addington, C. E. Bearden, K. Cadenhead, B. Cornblatt, D. H. Mathalon, T. McGlashan, D. Perkins, L. J. Seidman, T. D. Cannon, and +5 additional authors
Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort, Y. Chung, D. Alswede, J. Addington, C. E. Bearden, K. Cadenhead, B. Cornblatt, D. H. Mathalon, T. McGlashan, D. Perkins, T. D. Cannon, and +6 additional authors
Patches: Established and emerging transdermal treatments in psychiatry, L. Citrome, C. M. Zeni, and C. U. Correll
84 Assessment of Current Clinical Practices in Recognizing and Treating Bipolar Disorder, C. U. Correll, P. Chatterjee, S. H. Gitzinger, J. Lubarda, and M. Morgan
Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation, C. U. Correll, R. Jain, J. M. Meyer, A. Periclou, T. Carrothers, A. Barabassy, M. Patel, and W. Earley
Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics, C. U. Correll, J. K. Sliwa, D. M. Najarian, and S. R. Saklad
Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study, C. U. Correll, A. D. Stanford, A. Claxton, Y. Du, and P. J. Weiden
Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement, S. J. Curry, A. H. Krist, D. K. Owens, M. J. Barry, A. B. Caughey, K. W. Davidson, C. A. Doubeni, J. W. Epling, D. C. Grossman, J. B. Wong, and +7 additional authors
Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement, S. J. Curry, A. H. Krist, D. K. Owens, M. J. Barry, A. B. Caughey, K. W. Davidson, C. A. Doubeni, J. W. Epling, A. R. Kemper, J. B. Wong, and +6 additional authors
Screening for social determinants of health: The known and unknown, K. W. Davidson and T. McGinn
Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function (vol 9, 2098, 2018), G. Davies, M. Lam, S. E. Harris, J. W. Trampush, M. Luciano, P. DeRosse, J. Yu, A. Malhotra, T. Lencz, I. J. Deary, and +212 additional authors
Deconstructing Avolition: Initiation vs persistence of reward-directed effort, P. DeRosse, A. D. Barber, C. L. Fales, and A. K. Malhotra
Examining the relationship between perinatal depression and neurodevelopment in infants and children through structural and functional neuroimaging research, C. Duan, M. M. Hare, M. Staring, and K. M. Deligiannidis
Correction: Posttraumatic Stress Disorder Prevalence and Risk of Recurrence in Acute Coronary Syndrome Patients: A Meta-analytic Review., D. Edmondson, S. Richardson, L. Falzon, K. W. Davidson, M. A. Mills, and Y. Neria
Psychosocial Screening in Disorders/Differences of Sex Development: Psychometric Evaluation of the Psychosocial Assessment Tool, M. M. Ernst, M. Gardner, C. A. Mara, E. C. Délot, P. Y. Fechner, M. Fox, M. M. Rutter, P. W. Speiser, C. Foley, B. Yashar, and +24 additional authors
Childhood factors associated with increased risk for mood episode recurrences in bipolar disorder—A systematic review, X. Estrada-Prat, A. R. Van Meter, E. Camprodon-Rosanas, S. Batlle-Vila, B. I. Goldstein, and B. Birmaher
An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder, G. L. Faedda, R. J. Baldessarini, C. Marangoni, A. Bechdolf, M. Berk, B. Birmaher, P. Conus, M. P. DelBello, A. C. Duffy, C. U. Correll, and +12 additional authors
Disentangling Efficacy and Expectations: A Prospective, Cross-lagged Panel Study of Cancer Survivors' Physical Activity, E. A. Fallon, R. L. Stephens, B. McDonald, M. Diefenbach, and C. R. Leach
Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study, R. L. Findling, N. K. McNamara, M. Pavuluri, J. A. Frazier, M. Rynn, R. Scheffer, V. Kafantaris, A. Robb, M. DelBello, P. Taylor-Zapata, and +7 additional authors
How the DSM is used in clinical practice, M. B. First, M. D. Erlich, D. A. Adler, S. Leong, L. B. Dixon, D. W. Oslin, B. Goldman, S. Koh, B. Levine, S. G. Siris, and +1 additional author
The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness, J. Firth, N. Siddiqi, A. Koyanagi, D. Siskind, S. Rosenbaum, C. Galletly, S. Allan, C. Caneo, C. U. Correll, B. Stubbs, and +32 additional authors
Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services, J. H. Foss-Feig, E. Velthorst, L. Smith, A. Reichenberg, J. Addington, K. S. Cadenhead, B. A. Cornblatt, D. H. Mathalon, T. H. McGlashan, C. E. Bearden, and +8 additional authors
Longitudinal outcomes in pediatric- and adult-onset bipolar patients compared to healthy and schizophrenia controls, M. Frahm Laursen, J. B. Valentin, R. W. Licht, C. U. Correll, and R. E. Nielsen
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development, A. Frieder, M. Fersh, R. Hainline, and K. M. Deligiannidis
Breadth and depth of working memory and executive function compromises in mild cognitive impairment and their relationships to frontal lobe morphometry and functional competence, L. Garcia-Alvarez, J. J. Gomar, A. Sousa, M. P. Garcia-Portilla, and T. E. Goldberg
Longitudinal changes in brain function associated with symptom improvement in youth with PTSD, A. Garrett, J. A. Cohen, S. Zack, V. Carrion, B. Jo, J. Blader, A. Rodriguez, T. J. Vanasse, A. L. Reiss, and W. S. Agras
Genome-wide Association Study of Maximum Habitual Alcohol Intake in > 140,000 US European and African American Veterans Yields Novel Risk Loci, J. Gelernter, N. Sun, R. Polimanti, R. H. Pietrzak, D. F. Levey, Q. Lu, Y. Hu, B. Li, T. Lencz, M. B. Stein, and +18 additional authors
The role of a family history of psychosis for youth at clinical high risk of psychosis, G. Georgopoulos, J. Stowkowy, L. Liu, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, T. H. McGlashan, D. O. Perkins, L. J. Seidman, J. Addington, and +5 additional authors
Best practices for evaluation and treatment of agitated children and adolescents (Beta) in the emergency department: Consensus statement of the American Association for Emergency psychiatry, R. Gerson, N. Malas, V. Feuer, G. H. Silver, R. Prasad, and M. M. Mroczkowski
Erratum: Best practices for evaluation and treatment of agitated children and adolescents (Beta) in the emergency department: Consensus statement of the American Association for Emergency psychiatry (Western Journal of Emergency Medicine (2019) 20:2 (409-419) DOI: 10.5811/westjem.2019.1.41344), R. Gerson, N. Malas, V. Feuer, G. H. Silver, R. Prasad, and M. M. Mroczkowski
Erratum: This article corrects: Best practices for evaluation and treatment of agitated children and adolescents (Beta) in the emergency department: Consensus statement of the American Association for Emergency psychiatry (Western Journal of Emergency Medicine (2019) 20: 2 (409-419) DOI: 10.5811/westjem.2019.1.41344), R. Gerson, N. Malas, V. Feuer, G. H. Silver, R. Prasad, and M. M. Mroczkowski
Mullerian inhibiting substance, sex hormone binding globulin and sex hormone levels in stimulant-naive, first-diagnosed prepubertal boys with attention-deficit/hyperactivity disorder: comparison with matched healthy controls as well as before and after oros-methylpenidate treatment, C. Gokcen, A. B. Erbagci, T. Mutluer, M. Orkmez, and C. U. Correll
Use of Behavioral Economics to Improve Medication Adherence in Severe Mental Illness., D. Guinart and J. M. Kane
Predicting psychosis risk using a specific measure of cognitive control: A 12-month longitudinal study, J. Y. Guo, T. A. Niendam, A. M. Auther, R. E. Carrión, B. A. Cornblatt, J. D. Ragland, S. Adelsheim, R. Calkins, T. G. Sale, C. S. Carter, and +2 additional authors
Association between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome, H. K. Hamilton, B. J. Roach, P. M. Bachman, A. Belger, R. E. Carrion, E. Duncan, J. K. Johannesen, G. A. Light, B. A. Cornblatt, D. H. Mathalon, and +11 additional authors
Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness, C. Hawco, R. W. Buchanan, N. Calarco, B. H. Mulsant, M. Argyelan, P. DeRosse, A. K. Malhotra, X. Zhou, P. Homan, M. Green, and +19 additional authors
Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016, M. Hojlund, A. Pottegard, E. Johnsen, R. A. Kroken, J. Reutfors, P. Munk-Jorgensen, and C. U. Correll
Structural similarity networks predict clinical outcome in early-phase psychosis, P. Homan, M. Argyelan, P. DeRosse, P. R. Szeszko, J. A. Gallego, L. Hanna, D. G. Robinson, J. M. Kane, T. Lencz, and A. K. Malhotra
Striatal volume and functional connectivity correlate with weight gain in early-phase psychosis, P. Homan, M. Argyelan, C. L. Fales, A. D. Barber, P. DeRosse, P. R. Szeszko, D. G. Robinson, T. Lencz, and A. K. Malhotra
Author Correction: Neural computations of threat in the aftermath of combat trauma (Nature Neuroscience, (2019), 22, 3, (470-476), 10.1038/s41593-018-0315-x), P. Homan, I. Levy, E. Feltham, C. Gordon, J. Hu, J. Li, R. H. Pietrzak, S. Southwick, J. H. Krystal, D. Schiller, and +1 additional author
Neural computations of threat in the aftermath of combat trauma, P. Homan, I. Levy, E. Feltham, C. Gordon, J. Hu, J. Li, R. H. Pietrzak, S. Southwick, J. H. Krystal, D. Schiller, and +1 additional author
Gene expression imputation across multiple brain regions provides insights into schizophrenia risk, L. M. Huckins, A. Dobbyn, D. M. Ruderfer, G. Hoffman, W. Wang, A. F. Pardinas, V. M. Rajagopal, T. D. Als, A. K. Malhotra, P. F. Sullivan, and +343 additional authors
Behavioral economics implementation: Regret lottery improves mHealth patient study adherence., S. A. Husain, K. Diaz, J. E. Schwartz, F. E. Parsons, M. M. Burg, K. W. Davidson, and I. M. Kronish
Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study, N. Iwata, J. Ishigooka, W. H. Kim, B. H. Yoon, S. K. Lin, A. H. Sulaiman, R. Cosca, L. Wang, C. U. Correll, J. M. Kane, and +7 additional authors
Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial., K. G. Jensen, C. U. Correll, D. Rudå, D. G. Klauber, M. S. Decara, B. Fagerlund, J. R.M. Jepsen, F. Eriksson, A. Fink-Jensen, and A. K. Pagsberg
Medication-Assisted Treatment for Opioid Use Disorder in Older Adults: An Emerging Role for the Geriatric Psychiatrist, P. Joshi, N. K. Shah, and H. D. Kirane
Clinical guidance on the identification and management of treatment-resistant schizophrenia, J. M. Kane, O. Agid, M. L. Baldwin, O. Howes, J. P. Lindenmayer, S. Marder, M. Olfson, S. G. Potkin, and C. U. Correll
Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia, J. M. Kane and C. U. Correll
Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable A Database Report and Case Study, J. M. Kane, C. U. Correll, N. Delva, S. Gopal, A. Savitz, and M. Mathews
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial, J. M. Kane, N. R. Schooler, P. Marcy, E. D. Achtyes, C. U. Correll, and D. G. Robinson
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions, S. Kaptoge, L. Pennells, D. De Bacquer, M. T. Cooney, M. Kavousi, G. Stevens, L. M. Riley, S. Savin, K. W. Davidson, J. Danesh, and +90 additional authors
Addressing the opioid crisis: An assessment of clinicians' training experience, practices, and attitudes within a large healthcare organization, H. Kirane, E. Drits, S. Ahn, S. Kapoor, J. Morgenstern, J. Conigliaro, and J. Enden
Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons, T. Kishimoto, K. Hagi, M. Nitta, J. M. Kane, and C. U. Correll
Structural brain characteristics in treatment-resistant depression: review of magnetic resonance imaging studies, M. P. Klok, P. F. van Eijndhoven, M. Argyelan, A. H. Schene, and I. Tendolkar
Mapping Cortical and Subcortical Asymmetry in Obsessive-Compulsive Disorder: Findings From the ENIGMA Consortium, X. Z. Kong, P. S. Boedhoe, Y. Abe, P. Alonso, S. H. Ameis, P. D. Arnold, F. Assogna, J. T. Baker, P. R. Szeszko, A. Falini, and +90 additional authors
Animal Models of Psychosis in Alzheimer Disease, J. M. Krivinko, J. Koppel, A. Savonenko, and R. A. Sweet
Keeping up with the therapeutic advances in schizophrenia: A review of novel and emerging pharmacological entities, A. Krogmann, L. Peters, L. Von Hardenberg, K. Bödeker, V. B. Nöhles, and C. U. Correll
Increasing the Precision of Hypertension Treatment Through Personalized Trials: a Pilot Study, I. M. Kronish, Y. K. Cheung, D. Shimbo, J. Julian, B. Gallagher, F. Parsons, and K. W. Davidson
Examining motivational interviewing's effect on confidence and commitment using daily data, A. Kuerbis, K. G. Lynch, S. Shao, and J. Morgenstern
Psychiatrists' perceptions of medication adherence among patients with schizophrenia: An international survey, S. Kurokawa, T. Kishimoto, K. Su, J. P. Chang, H. Chang, X. Yu, N. Rodrigues-Silva, J. Nielsen, G. Petrides, J. M. Kane, and +10 additional authors
Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways, M. Lam, W. D. Hill, J. W. Trampush, J. Yu, E. Knowles, G. Davies, E. Stahl, P. DeRosse, A. K. Malhotra, T. Lencz, and +58 additional authors
High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine, J. R. Larsen, C. K. Svensson, L. Vedtofte, M. L. Jakobsen, H. S. Jespersen, M. I. Jakobsen, K. Koyuncu, O. Schjerning, C. U. Correll, A. Fink-Jensen, and +4 additional authors
International Society of Psychiatric Genetics Ethics Committee: Issues facing us, G. Lázaro-Muñoz, M. Sabatello, L. Huckins, H. Peay, F. Degenhardt, B. Meiser, T. Lencz, T. Soda, A. Docherty, L. K. Davis, and +3 additional authors
A user centered design approach to development of an online self-management program for cancer survivors: Springboard Beyond Cancer, C. R. Leach, M. A. Diefenbach, S. Fleszar, C. M. Alfano, R. L. Stephens, K. Riehman, and S. V. Hudson
Impact of individual- and area-level race/ethnicity on illness intrusiveness among cancer survivors., C. R. Leach, R. N. Vereen, A. V. Rao, K. Ross, and M. A. Diefenbach
Can delay discounting deliver on the promise of RDoC?, K. M. Lempert, J. E. Steinglass, A. Pinto, J. W. Kable, and H. B. Simpson
Stress perception following childhood adversity: Unique associations with adversity type and sex, A. M. Lopilato, J. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, D. H. Mathalon, T. H. McGlashan, D. O. Perkins, E. F. Walker, and +2 additional authors
Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis, A. M. LoPilato, K. Goines, J. Addington, C. E. Bearden, K. S. Cadenhead, T. D. Cannon, B. A. Cornblatt, D. H. Mathalon, T. H. McGlashan, E. F. Walker, and +4 additional authors
Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment, M. Mackay, A. Vo, C. C. Tang, W. Anderson, N. J. Ploran, C. Aranow, P. Watson, B. T. Volpe, B. Diamond, D. Eidelberg, and +5 additional authors
Assessing the Candidates, A. K. Malhotra
Association Between Duration of Untreated Psychosis and Frontostriatal Connectivity During Maintenance of Visuospatial Working Memory, A. Manivannan, W. Foran, M. Jalbrzikowski, V. P. Murty, G. L. Haas, G. Tarcijonas, B. Luna, and D. K. Sarpal
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia, W. F. Martin, C. U. Correll, P. J. Weiden, Y. Jiang, S. Pathak, L. DiPetrillo, B. L. Silverman, and E. W. Ehrich
Transcranial Magnetic Stimulation for Positive Symptoms in Schizophrenia: A Systematic Review, T. Marzouk, S. Winkelbeiner, H. Azizi, A. K. Malhotra, and P. Homan
Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies., T. Masuda, F. Misawa, M. Takase, J. Kane, and C. U. Correll
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia, M. Mathews, S. Gopal, I. Nuamah, L. Hargarter, A. J. Savitz, E. Kim, W. Tan, B. Soares, and C. U. Correll
Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis, K. Matsui, T. Tokumasu, Y. Takekita, K. Inada, T. Kanazawa, T. Kishimoto, S. Takasu, H. Tani, S. Tarutani, H. Takeuchi, and +3 additional authors
Feasibility and Impact of a Guided Symptom Exposure Augmented Cognitive Behavior Therapy Protocol to Prevent Symptoms of Pharmacologically Induced Depression: A Pilot Study, L. K. McGinn, A. Van Meter, I. Kronish, J. Gashin, K. Burns, N. Kil, and T. G. McGinn
67 Effects of Long-term Valbenazine on Psychiatric Status in Patients with Tardive Dyskinesia and a Primary Mood Disorder, R. S. McIntyre, G. Remington, C. U. Correll, R. Weber, K. Farahmand, L. Lundt, J. Burke, and S. Siegert
Brexanolone Injection in Postpartum Depression: Two Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trials, S. Meltzer-Brody, H. Colquhoun, R. Riesenberg, C. N. Epperson, K. M. Deligiannidis, D. R. Rubinow, H. Li, A. J. Sankoh, C. Clemson, S. Kanes, and +2 additional authors
Psychosis screening in schools: Considerations and implementation strategies, M. S. Meyer, A. Rosenthal, K. A. Bolden, R. L. Loewy, M. Savill, R. Shim, J. Rodriguez, V. Flores, E. Pavao, and T. A. Niendam
Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study, A. J. Mitchell, D. Vancampfort, P. Manu, C. U. Correll, M. Wampers, R. Van Winkel, W. Yu, and M. De Hert